SB3701 Summary

• Expands Prescription Monitoring Program (PMP) documentation requirement from initial Schedule II narcotic prescriptions to all Schedule II, III, IV, and V controlled substance prescriptions, with exceptions for oncology, palliative care, and emergency department supplies of 7 days or less.

• Requires prescribers or their designees to document attempts to access patient information in the Illinois PMP when issuing controlled substance prescriptions and to record this in the patient's medical record.

• Makes having an Illinois Prescription Monitoring Program account a condition of licensure and license renewal for all prescribers holding an Illinois Controlled Substance license through the Department of Financial and Professional Regulation.

• Authorizes the PMP to issue unsolicited reports to prescribers and pharmacies when a patient has contacted 5 or more prescribers or pharmacies within a 6-month period, indicating potential medication shopping.

• Prohibits adverse employment, credentialing, contracting, licensure, or evaluation actions against prescribers or dispensers based on patient feedback opposing their clinical decision not to prescribe controlled substances.